Torsades de pointes with high-dose loperamide.

J Electrocardiol

Department of Internal Medicine, Vanderbilt University Medical Center, 1161 21st Avenue South, D-3100 Medical Center North, Nashville, TN.

Published: February 2018

Case: A 41year-old male presented with torsades de pointes. The patient was taking over 100mg of loperamide per day to self-medicate for chronic pain. Coronary angiography, cardiac magnetic resonance imaging, and genetic testing were negative for pre-disposing ischemia, cardiomyopathy, or genetic variant respectively.

Conclusions: Patients without predisposing genetic or cardiac abnormalities are at risk of life-threatening QTc prolongation and torsades with use of high-dose loperamide. The authors suggest consideration of regulating the quantity of loperamide that can be purchased at a single time similar to the regulations in place for other over-the-counter medications with high potential for misuse.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jelectrocard.2017.01.011DOI Listing

Publication Analysis

Top Keywords

torsades pointes
8
high-dose loperamide
8
pointes high-dose
4
loperamide
4
loperamide case
4
case 41year-old
4
41year-old male
4
male presented
4
presented torsades
4
pointes patient
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!